Marc Gautier

• Led regional project teams (new AI and Strategic Product Lifecycle Management), promoting clear, complete and transparent exchanges of information for optimal alignment across functions and reliable fact-based decision-making. • Identified, documented, and proactively managed project risks and opportunities to ensure rigorous control of the development process. • Presented project team recommendations to governance review body, addressed concerns and followed-up endorsement with agreed actions.

• Executed project management activities to support registration of new formulations and combinations in Europe and China. • Ensured regular and meaningful project communications, including dashboards, reports and metrics, to enable timely information and analyses to key stakeholders and decision makers. • Reviewed timelines and analysed interdependencies within Cardiovascular & Metabolism projects to produce standard integrated project plan.

• Strengthened business development processes, with a focus on due diligence, to ensure speed and efficiency in deal making. • Developed an intranet tool to monitor activities and outcomes, with thorough records documenting interactions with target partner companies. • Introduced guidelines for comprehensive and consistent reporting across all our functional business partners (IP/Legal, Finance, Clinical, Regulatory, Manufacturing & Marketing)

• Facilitated cross-functional teams work and progress (5 to 20 members) in a matrix environment to introduce GARDASIL®, the first vaccine against cervical cancer. • Planned across functions, optimised lead times with stakeholders, resulting in product launch in 17 European countries in just 6 months. • Coordinated resources with our American shareholder to meet milestones and deadlines: marketing authorisation obtained 3 months before target date.